GJA1 and breast carcinoma: Because it is possible that differential activities for Cx43 are relevant in breast cancer, a method for examining endogenous Cx43 activity at gap junctions would be instrumental in clarifying the role of Cx43 in breast cancer and the therapeutic potential of targeting this molecule.